Health and Fitness Health and Fitness
Wed, January 19, 2011
[ Wed, Jan 19th 2011 ] - Market Wire
Geron Initiates Phase 2 Clinical Trial of Imetelstat in Essential Thrombocythemia
Tue, January 18, 2011
[ Tue, Jan 18th 2011 ] - Market Wire
Illumina to Open Latin America Office
[ Tue, Jan 18th 2011 ] - Market Wire
Illumina Launches the Illumina Agricultural Great .. lp Reduce Global Hunger, Malnutrition and Poverty
[ Tue, Jan 18th 2011 ] - Market Wire
Impax Laboratories Corrects Inaccurate Informatio .. rtunities Discussed in Several Financial Articles
[ Tue, Jan 18th 2011 ] - Market Wire
Centric Health Comments on Recent Market Activity
[ Tue, Jan 18th 2011 ] - Market Wire
Medtronic Revises Design of CoreValve® U.S. Pivotal Trial
[ Tue, Jan 18th 2011 ] - Market Wire
ImmunoGen, Inc. Appoints Theresa Wingrove, Ph.D., as Vice President, Regulatory Affairs
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien apresenta sistema de stents perif©ricos EverFlex+a" de prxima gerao
[ Tue, Jan 18th 2011 ] - Market Wire
IntegraMed Expands Fertility Partner Network via Acquisition of Seattle, WA Fertility Center
[ Tue, Jan 18th 2011 ] - Market Wire
Four Rivers (operating as Verta Energy) Appoints Leading UK Renewable Energy Experts
[ Tue, Jan 18th 2011 ] - Market Wire
Baeta Corp. Chosen as Best Stock Pick of the Year by Prominent Hedge Fund
[ Tue, Jan 18th 2011 ] - Market Wire
Cancer Patients in South Africa Gain Access to Ad .. diotherapy Treatments from Varian Medical Systems
[ Tue, Jan 18th 2011 ] - Market Wire
Biomoda Featured on Business Radio
[ Tue, Jan 18th 2011 ] - Market Wire
Forest Laboratories, Inc. Reports Fiscal Third Qu .. e of $1.11 Including a $0.23 Per Share Charge for
[ Tue, Jan 18th 2011 ] - Market Wire
Alkermes Elects Wendy L. Dixon, Ph.D., to Board of Directors
[ Tue, Jan 18th 2011 ] - Market Wire
ARIAD Announces Oral Ridaforolimus Achieved Prima .. ression-Free Survival in Patients with Metastatic
[ Tue, Jan 18th 2011 ] - Market Wire
Oncolytics Biotech® Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien???????EverFlex+a" ??????
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien introduceert nieuwe generatie EverFlex+ Peripheral Stent System
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien revela el sistema de stents perif©ricos EverFlex+a" de prxima generacin
[ Tue, Jan 18th 2011 ] - Market Wire
Creative Learning Corporation Continues Its International Expansion
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien d©voile son systme de stent p©riph©rique EverFlex+a" de nouvelle g©n©ration
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien presenta un sistema di stent periferici di nuova generazione EverFlex+a"
[ Tue, Jan 18th 2011 ] - Market Wire
Covidien stellt EverFlex+a" vor, sein peripheres Stentsystem der nchsten Generation
Mon, January 17, 2011
[ Mon, Jan 17th 2011 ] - Market Wire
Covidien Unveils Next Generation EverFlex+a" Peripheral Stent System
[ Mon, Jan 17th 2011 ] - Market Wire
Leisureworld Announces January Dividend
[ Mon, Jan 17th 2011 ] - Market Wire
Life Technologies Sets 4th Quarter and Full Year .. nings Release Date for Thursday, February 3, 2011
[ Mon, Jan 17th 2011 ] - Market Wire
The State of Israel's Nationwide Blood Banks Comm .. isafe 1 Technologies Corporation's Pre-Matching D
[ Mon, Jan 17th 2011 ] - Market Wire
Emeritus Announces Appointment of Granger Cobb as Chief Executive Officer
Fri, January 14, 2011
[ Fri, Jan 14th 2011 ] - Market Wire
Biogen Idec to Report Fourth Quarter and Year End 2010 Financial Results on February 1, 2011

Biogen Idec to Report Fourth Quarter and Year End 2010 Financial Results on February 1, 2011


Published on 2011-01-14 13:50:25 - Market Wire
  Print publication without navigation


WESTON, Mass.--([ BUSINESS WIRE ])--Biogen Idec Inc. (NASDAQ:BIIB) today announced it will report fourth quarter and year end 2010 financial results on Tuesday, February 1, 2011, before the financial markets open.

Following the release of the financials, the Company will host a live webcast where Biogen Idec management will discuss the financial results, at 8:30 am ET. To access the live webcast, please go to the investor relations section of Biogen Ideca™s website at [ www.biogenidec.com ]. Following the live webcast, an archived version of the call will be available at the same URL, for one month.

About Biogen Idec

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit [ www.biogenidec.com ].

Contributing Sources